HVC
COLL icon

Healthcare Value Capital’s Collegium Pharmaceutical COLL Stock Holding History

Healthcare Value Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100,000
Closed -$2.36M – 26
2021
Q2 		$2.36M Hold
100,000
– – 4.71% 11
2021
Q1 		$2.37M Buy
+100,000
New +$2.38M 5.28% 7

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Healthcare Value Capital's COLL Position: Q3 2021 in Review

Healthcare Value Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2021, closing a stake of 100,000 shares — an estimated $2.36M sold.

Healthcare Value Capital first reported a position in COLL in Q1 2021 and held it in 2 quarters. The position peaked at $2.37M in Q1 2021. 154 funds tracked by Wall St. Rank hold COLL as of Q3 2021.

  • Healthcare Value Capital reported no remaining Collegium Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Healthcare Value Capital sold 100,000 Collegium Pharmaceutical shares in Q3 2021, an estimated $2.36M.
  • Healthcare Value Capital first reported a position in Collegium Pharmaceutical in Q1 2021 and held it in 2 quarters.
  • Healthcare Value Capital's Collegium Pharmaceutical position peaked at $2.37M in Q1 2021.
  • 154 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.